Compare KODK & OFIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KODK | OFIX |
|---|---|---|
| Founded | 1880 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 658.4M | 500.2M |
| IPO Year | 1994 | 1998 |
| Metric | KODK | OFIX |
|---|---|---|
| Price | $6.97 | $11.70 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $17.25 |
| AVG Volume (30 Days) | ★ 559.1K | 284.1K |
| Earning Date | 06-23-2026 | 05-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 29.39 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $4,114,000,000.00 | $822,312,000.00 |
| Revenue This Year | N/A | $6.32 |
| Revenue Next Year | N/A | $6.01 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 2.85 |
| 52 Week Low | $4.93 | $10.25 |
| 52 Week High | $9.96 | $17.00 |
| Indicator | KODK | OFIX |
|---|---|---|
| Relative Strength Index (RSI) | 41.84 | 26.81 |
| Support Level | $6.94 | $10.55 |
| Resistance Level | $7.09 | $13.96 |
| Average True Range (ATR) | 0.31 | 0.57 |
| MACD | -0.02 | -0.10 |
| Stochastic Oscillator | 28.52 | 0.79 |
Eastman Kodak Co is a United States-based company. It operates through several business segments; Print, Brand, and Advanced Materials and Chemicals. The Print segment which derives the majority of revenue includes products like digital offset plate offerings and computer-to-plate imaging solutions, high-quality digital printing solutions using electrically charged toner-based technology, production press systems, consumables, inkjet components, software and services. Geographically, the company generates revenue from the United States, Canada, Europe, Middle East and Africa, Asia Pacific, and Latin America.
Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two reportable segments: Global Spine and Global Limb Reconstruction. The Global Spine segment offers bone growth therapies, spinal implants, biologics, and enabling technologies used in spinal procedures. The Global Limb Reconstruction segment provides products and solutions for limb deformity correction, limb lengthening, fracture management, and limb preservation, supported by digital technologies. It generates the majority of its revenue from the Global Spine segment.